Switch From Mounjaro to Wegovy and Save Money

  • Save money with Wegovy starting at £79.99 (after FIRST40 discount) compared to other GLP-1 treatments
  • Switch seamlessly with EverydayMeds stocking both Mounjaro and Wegovy for uninterrupted supply
  • Better travel convenience with Wegovy's 6-week room temperature storage vs Mounjaro's 21-day limit
  • Expert clinical assessment ensures safe transition between medications with proper dose conversion
Start free consultation

Treatment from £144.99

Takes under 2 minutes · 100% online
Person enjoying the outdoors

Check if you're eligible

Height 175 cm
Weight 82 kg
Your BMI
26.8
Check with prescriber
Start free consultation
Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
100% UK-based pharmacy Free advice & support Rated Excellent 2,400+ reviews
Which route suits you

Two clinically backed paths to results

A weekly GLP-1 injection or a daily capsule — each fully overseen by our UK pharmacy team, with no obligation to continue.

Treatment
Avg. weight loss
05%10%15%20%25%
Availability
Injection
Weekly pen · GLP-1
Avg. weight loss
~20%up to
Availability Available now
Pill NEW
Daily tablet · Oral GLP-1
Avg. weight loss
~17%up to
Availability Explore now
Live Pricing

Our Range

Prices update live and may change. The live table below always takes precedence.
All treatment is subject to a prescriber consultation and clinical approval.

Safe Switching Between GLP-1 Weight Management Treatments

Can I Swap From Mounjaro to Wegovy: Understanding Your Switch & Save Options

If you're wondering "can I swap from Mounjaro to Wegovy", you're joining thousands of patients exploring their weight management options for better outcomes or cost savings. The key difference lies in their mechanisms: Mounjaro contains tirzepatide (a dual GIP and GLP-1 receptor agonist), whilst Wegovy contains semaglutide (a single GLP-1 receptor agonist). Both are prescription-only medicines requiring clinical supervision, but switching between them can offer advantages including potential cost savings, improved side effect profiles, or better availability. At EverydayMeds, we understand that your weight management journey may require adjustments, which is why we stock both treatments to support seamless transitions under proper medical guidance.

The decision to swap from Mounjaro to Wegovy often stems from practical considerations including cost differences, storage requirements, or individual response variations. EverydayMeds' clinical team reviews each switching request individually, ensuring appropriate dose conversions and timing protocols are followed. Our GPhC-registered pharmacy (#9012878) maintains both medications in optimal cold-chain storage, so patients can transition without supply interruptions. When you're ready to explore whether switching aligns with your treatment goals, our streamlined assessment process makes the transition straightforward whilst maintaining the clinical rigour required for these prescription-only medicines.

Wegovy Pricing & Value: Your Switch & Save Opportunity

Understanding the cost implications when you swap from Mounjaro to Wegovy reveals significant potential savings through EverydayMeds' competitive pricing structure. Our Wegovy treatment begins at £79.99 for the 0.25mg starter dose (with FIRST40 discount applied at checkout), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers benefit from the FIRST40 discount code, whilst returning customers use DOSE25, both applied automatically at checkout to reach these final prices. Our bundle options like the Intro Duo (0.25mg & 0.5mg pens for £169.99) provide convenient starter packages, whilst the Ultimate Stability Trio offers three months of maintenance supply at 2.4mg for £649.99.

The financial advantages of choosing to swap from Mounjaro to Wegovy become clear when comparing long-term treatment costs and availability factors. EverydayMeds' transparent pricing eliminates hidden fees common with other suppliers, and our bundle configurations allow patients to secure multiple months of treatment in single orders. Additionally, our discount codes apply to all orders, ensuring consistent savings whether you're starting your switch or maintaining long-term treatment. The combination of competitive pricing, reliable supply chains, and clinical support makes EverydayMeds the logical choice for patients considering cost-effective weight management transitions.

Clinical Evidence Supporting Your Decision to Swap From Mounjaro to Wegovy

The STEP clinical trial programme provides robust evidence for Wegovy's efficacy in supporting weight management when patients choose to swap from other treatments. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 demonstrated that patients with type 2 diabetes experienced around 9.6% weight reduction, whilst STEP 3 showed approximately clinically studied weight loss when combined with intensive behavioural therapy.

The SELECT cardiovascular outcomes trial further supports the decision for eligible patients to swap from Mounjaro to Wegovy, demonstrating a 20% reduction in major cardiovascular events (hazard ratio 0.80). These clinical findings, combined with STEP 5's demonstration of sustained clinically studied weight loss at two years, provide confidence for patients and prescribers considering treatment switches. However, individual responses vary, and the decision to transition should always be made through proper clinical assessment rather than based solely on trial averages.

How Wegovy Works When You Swap From Mounjaro: Mechanism Differences

Understanding how Wegovy functions differently from Mounjaro helps explain why some patients benefit from making the switch between these prescription-only medicines. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone, binding specifically to GLP-1 receptors in the brain's appetite control centres. This targeted approach reduces appetite signals, promotes satiety after smaller meals, and may help diminish food cravings by working directly on neural pathways controlling hunger. Unlike Mounjaro's dual-hormone approach targeting both GIP and GLP-1 receptors, Wegovy's single-pathway mechanism can offer different side effect profiles and response patterns. The once-weekly injection schedule remains consistent between treatments, making the practical transition smoother for patients accustomed to weekly dosing routines. Clinical experience suggests some patients respond better to semaglutide's focused GLP-1 action, particularly those who experienced specific side effects with dual-receptor treatments.

EverydayMeds Ordering Process: Seamless Transition When You Swap From Mounjaro to Wegovy

Our streamlined process makes it straightforward to swap from Mounjaro to Wegovy through our GPhC-registered online pharmacy service (#9012878). The journey begins with our comprehensive 3-minute clinical assessment, specifically designed to evaluate switching scenarios and ensure appropriate dose conversions between different GLP-1 treatments. Our qualified prescribers review each switching request within 3 working days (or 24 hours with express service), considering your previous treatment response, current dose, and individual health factors. Once approved, your Wegovy prescription ships via next-day delivery using our temperature-controlled cold-chain logistics, ensuring the medication arrives in optimal condition. The entire process typically completes within one week, allowing seamless transition without treatment gaps that could affect your weight management progress.

Storage & Practical Advantages: Why Patients Swap From Mounjaro to Wegovy

One compelling reason patients choose to swap from Mounjaro to Wegovy involves practical storage advantages that enhance treatment convenience. Wegovy's FlexTouch pen system tolerates room temperature storage for up to 6 weeks once removed from refrigeration (below 30°C), compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers, patients with limited refrigeration access, or those seeking greater dosing flexibility. Both medications require initial refrigerated storage at 2-8°C, but Wegovy's superior temperature tolerance reduces stress around meal timing, travel schedules, and emergency situations. The dose escalation protocol remains similar between treatments, starting at 0.25mg and increasing monthly, though the specific timing of your switch will depend on your current Mounjaro dose and clinical response. These practical advantages, combined with the identical weekly injection schedule, make transitioning between treatments more manageable for many patients.

Personalised Switch Strategies: Tailored Approaches When You Swap From Mounjaro to Wegovy

Every patient's decision to swap from Mounjaro to Wegovy requires individualised assessment of their current treatment status, response history, and specific switching motivations. Our clinical team evaluates factors including your present Mounjaro dose, treatment duration, side effect experiences, and weight management progress to determine optimal transition protocols. Some patients benefit from direct dose conversions, whilst others may require modified escalation schedules to minimise adjustment effects during the switching period. The transition strategy also considers timing factors such as supply continuity, insurance coverage changes, or travel requirements that influence treatment selection.

EverydayMeds' experience with treatment switches allows us to provide nuanced guidance that generic switching protocols cannot match. We recognise that patients choosing to swap from Mounjaro to Wegovy may have different underlying motivations requiring tailored support approaches. Whether you're switching due to cost considerations, side effect management, availability issues, or simply seeking treatment optimisation, our clinical assessment process addresses these specific factors. This personalised approach ensures your transition supports rather than disrupts your weight management journey, maintaining momentum towards your health goals throughout the switching process.

Start Your Switch Today: Expert Support for Mounjaro to Wegovy Transitions

Ready to explore whether you can swap from Mounjaro to Wegovy with potential cost savings and clinical benefits? EverydayMeds combines competitive pricing, expert clinical oversight, and seamless supply chains to support your treatment transition effectively. Our discount codes FIRST40 (new customers) and DOSE25 (returning customers) ensure you access our lowest prices, whilst our GPhC-registered pharmacy (#9012878) ensures pharmaceutical-grade quality and proper cold-chain handling. Begin your switching assessment today through our secure online platform, where qualified prescribers will evaluate your individual circumstances and guide you through the transition process safely. With both Mounjaro and Wegovy available through our service, you can switch with confidence knowing your supply continuity and clinical support remain uninterrupted. Visit our weight management collection at https://everydaymeds.co.uk/collections/weight-loss to start your clinical assessment and discover how switching could benefit your treatment journey.

Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026

NEW

GLP-1, now in adaily pill

Meet the daily GLP-1 tablet — needle-free, taken on your schedule, and prescribed by UK pharmacists. Designed for flexibility.

Join the free waitlist
Track your progress

Your journey,in your pocket

Track Now

Meet the newGLP-1 pill

  • Once-daily tablet · room-temp storage
  • No needles, no fridge
  • Up to ~15–17% in trials
How treatment works

How GLP-1 treatments help

Reduces appetite

Helps you feel fuller, sooner — so portions naturally shrink.

Curbs cravings

Quietens food noise so snacking and cravings ease off.

Slows digestion

Food stays in your stomach longer, steadying hunger between meals.

Steady blood sugar

Supports more stable glucose levels through the day.

Is GLP-1 treatment right for you?

GLP-1 medicines are powerful and prescription-only for good reason. They suit many people very well — and they aren’t appropriate for everyone. Here’s a clear, honest picture before you decide.

You may be suitable

Criteria met
BMI of 30 or higher
BMI of 27+ with weight-related conditions
Struggled to lose weight with diet alone
Ready to pair with lifestyle changes

Speak to us first

Potential risk
Pregnant, trying to conceive, or breastfeeding
History of certain thyroid cancers
Certain pancreatic or digestive conditions
Under the age of 18

Ready to start your journey?

Track your progress

Your journey, in your pocket

Track your journey

Log every dose and watch your progress build.

Download now Free to download — takes a minute to set up. App Store and Google Play

AI Meal Tracking. Built for GLP-1 Appetites.

Point your camera at any meal and in 4–6 seconds it logs the calories, macros, weight, and fullness it expects.

Never miss a dose

A daily nudge keeps you on track.

How it works

Achieve your goals in just a few simple steps.

Step 1

Start Free Consultation

Select safe UK treatments. Quick answers.

Step 2

Review By Our Clinical Team

Our expert team will use your consultation as the basis of our recommendation and communicate with you.

Step 3

Get it delivered fast

We’ll deliver direct to you, as quickly as tomorrow.

Trusted by thousands

Real people, real change

Hannah M.
Lost 2 st 4 lb in a year

“The cravings that used to run my evenings just quietened down. Having a pharmacist to message made it feel safe.”

David O.
Lost 3 st in a year

“Discreet, simple and genuinely supportive. The dose steps were explained clearly every time.”

Priya S.
Lost 1 st 9 lb in a year

“I finally feel like food isn’t the loudest thing in my head. The delivery was always discreet and on time.”

Frequently asked questions